As the demand for novel therapies and personalized medicine surges, leaders are uniquely positioned to create a culture of creativity, collaboration and innovation.
Pharmaceutical company Takeda is pioneering a technology-enabled, patient-centered future for plasma-derived therapies ...
Data-driven insights powered by advanced analytics and artificial intelligence (AI) help optimise project schedules, allocate ...
IRA has unintended consequences on investment landscape for small- and large-molecule drugs stifling the development of new ...
Hosted on MSN3d
National Conference on 'Pharma Innovations' Organized by Sri Aurobindo Institute of PharmacySri Aurobindo Institute of Pharmacy (SAIP), Indore, successfully hosted a National Conference on "Pharma Innovations: ...
In the rapidly evolving digital era, the pharmaceutical industry faces significant cybersecurity challenges, where data ...
Deborah McElhone, Head of Sustainability (Pharma) from CPI, argues that process intensification is a game changer for the ...
Shardul Nautiyal, Mumbai Monday, February 10, 2025, 14:30 Hrs [IST] ...
GlobalData on MSN1d
Royalty Pharma pays $250m for rights to Biogen’s lupus drugRoyalty Pharma has signed a deal to pay Biogen $250m to support the development of its late-stage experimental lupus ...
The ambitious plans aim to secure medicine supply, accelerate innovation, strengthen clinical research, and reinforce IP ...
The finest minds from the pharma firmament will also be sharing insights on the changing landscape and on the new imperatives ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback